COMPLEXA INC has a total of 45 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are YANGTZE RIVER PHARMACEUTICAL G, INST MEDIZINTECHNOLOGIE MAGDEB and BOLLAG WERNER.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | China | 4 | |
#6 | Israel | 3 | |
#7 | Brazil | 2 | |
#8 | Japan | 2 | |
#9 | Australia | 1 | |
#10 | Chile | 1 | |
#11 | Colombia | 1 | |
#12 | Costa Rica | 1 | |
#13 | India | 1 | |
#14 | Republic of Korea | 1 | |
#15 | Mexico | 1 | |
#16 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Electrotherapy | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Heterocyclic compounds | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Jorkasky Diane | 11 |
#2 | Miller Raymond A | 7 |
#3 | Cushing Daniel Joseph | 7 |
#4 | Freeman Bruce A | 6 |
#5 | Branchaud Bruce | 6 |
#6 | Daniel Joseph Cushing | 5 |
#7 | Batthyany Dighiero Carlos Ignacio | 3 |
#8 | Duran Rosario | 2 |
#9 | Bruce Branchaud | 2 |
#10 | Diane Jorkasky | 2 |
Publication | Filing date | Title |
---|---|---|
CA3000842A1 | Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids | |
WO2015073527A1 | Nitroalkene tocopherols and analogs thereof for use in the treatment and prevention of inflammation related conditions | |
WO2014204872A2 | Composition and method for inhibition of pkng from mycobacterium tuberculosis | |
US2013101514A1 | Compositions and methods for treating nephropathy | |
EP2590643A2 | Multi-component pharmaceuticals for treating diabetes | |
WO2012099557A2 | Fatty acid inhibitors | |
EP2483233A2 | Heteroatom containing substituted fatty acids | |
CN102083787A | Vinyl substituted fatty acids |